Astrocyte barriers to neurotoxic inflammation (original) (raw)

• Burda, J. E. & Sofroniew, M. V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81, 229–248 (2014).
  CAS PubMed PubMed Central Google Scholar
• Goverman, J. Autoimmune T cell responses in the central nervous system. Nature Rev. Immunol. 9, 393–407 (2009).
  CAS Google Scholar
• Ransohoff, R. M. & Engelhardt, B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nature Rev. Immunol. 12, 623–635 (2012).
  CAS Google Scholar
• Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nature Rev. Neurosci. 15, 300–312 (2014).
  CAS Google Scholar
• Barres, B. A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60, 430–440 (2008).
  CAS PubMed Google Scholar
• Sofroniew, M. V. & Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol. 119, 7–35 (2010).
  PubMed Google Scholar
• Sofroniew, M. V. Astrogliosis. Cold Spring Harb. Perspect. Biol. 7, a020420 (2014).
  Article PubMed Google Scholar
• Pekny, M. & Nilsson, M. Astrocyte activation and reactive gliosis. Glia 50, 427–434 (2005).
  PubMed Google Scholar
• Sofroniew, M. V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638–647 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kang, W. & Hebert, J. M. Signaling pathways in reactive astrocytes, a genetic perspective. Mol. Neurobiol. 43, 147–154 (2011).
  CAS PubMed PubMed Central Google Scholar
• Anderson, M. A., Ao, Y. & Sofroniew, M. V. Heterogeneity of reactive astrocytes. Neurosci. Lett. 565, 23–29 (2014).
  CAS PubMed Google Scholar
• Sofroniew, M. V. Reactive astrocytes in neural repair and protection. Neuroscientist 5, 400–407 (2005).
  Google Scholar
• Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nature Rev. Neurosci. 5, 146–156 (2004).
  CAS Google Scholar
• Hamby, M. E. & Sofroniew, M. V. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7, 494–506 (2010).
  CAS PubMed PubMed Central Google Scholar
• Verkhratsky, A. et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 4, e00082 (2012).
  PubMed PubMed Central Google Scholar
• Bianchi, M. G., Bardelli, D., Chiu, M. & Bussolati, O. Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease. Cell. Mol. Life Sci. 71, 2001–2015 (2014).
  CAS PubMed Google Scholar
• Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nature Rev. Immunol. 8, 279–289 (2008).
  CAS Google Scholar
• Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
  CAS PubMed Google Scholar
• Iwasaki, A. & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291–295 (2010).
  CAS PubMed PubMed Central Google Scholar
• Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12–18 (2007).
  CAS PubMed Google Scholar
• Owens, T., Bechmann, I. & Engelhardt, B. Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 67, 1113–1121 (2008).
  PubMed Google Scholar
• Broadwell, R. D. & Sofroniew, M. V. Serum proteins by-pass the blood brain barrier for extracellular entry to the CNS. Exp. Neurol. 120, 246–263 (1993).
  Google Scholar
• Engelhardt, B. & Coisne, C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 8, 4 (2011).
  PubMed PubMed Central Google Scholar
• Wilson, E. H., Weninger, W. & Hunter, C. A. Trafficking of immune cells in the central nervous system. J. Clin. Invest. 120, 1368–1379 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kawano, H. et al. Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res. 349, 169–180 (2012).
  PubMed PubMed Central Google Scholar
• Wanner, I. B. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33, 12870–12886 (2013).
  CAS PubMed PubMed Central Google Scholar
• Norton, W.T., Aquino, D.A., Hozumi, I., Chiu, F.C. & Brosnan, C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17, 877–885 (1992).
  CAS PubMed Google Scholar
• Bush, T. G. et al. Leukocyte infiltration, neuronal degeneration and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23, 297–308 (1999). This early transgenic loss-of-function study unexpectedly reveals that newly proliferated, scar-forming astrocytes restrict the spread of inflammatory cells after CNS damage.
  CAS PubMed Google Scholar
• Bush, T. G. et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93, 189–201 (1998).
  CAS PubMed Google Scholar
• Faulkner, J. R. et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143–2155 (2004). This transgenic loss-of-function study shows that newly proliferated, scar-forming astrocytes have important functions in protecting adjacent neural tissue and thereby help to improve outcome after CNS injury.
  CAS PubMed PubMed Central Google Scholar
• Li, L. et al. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28, 468–481 (2008).
  PubMed Google Scholar
• Voskuhl, R. R. et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29, 11511–11522 (2009).
  CAS PubMed PubMed Central Google Scholar
• Toft-Hansen, H., Fuchtbauer, L. & Owens, T. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59, 166–176 (2011).
  PubMed Google Scholar
• Liu, Z. et al. Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke. Glia 62, 2022–2033 (2014).
  PubMed PubMed Central Google Scholar
• Brosnan, C. F. & Raine, C. S. The astrocyte in multiple sclerosis revisited. Glia 61, 453–465 (2013).
  PubMed Google Scholar
• Eddleston, M. & Mucke, L. Molecular profile of reactive astrocytes — implications for their role in neurological disease. Neuroscience 54, 15–36 (1993).
  CAS PubMed Google Scholar
• Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391–6410 (2012). This study provides evidence for large-scale differences in transcriptome profiles of reactive astrocytes responding to different stimuli such as stroke or the bacterial protein LPS.
  CAS PubMed PubMed Central Google Scholar
• Hamby, M. E. et al. Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. J. Neurosci. 32, 14489–14510 (2012).
  CAS PubMed PubMed Central Google Scholar
• John, G. R., Lee, S. C., Song, X., Rivieccio, M. & Brosnan, C. F. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49, 161–176 (2005).
  PubMed Google Scholar
• Brambilla, R. et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145–156 (2005).
  CAS PubMed PubMed Central Google Scholar
• Okada, S. et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nature Med. 12, 829–834 (2006).
  CAS PubMed Google Scholar
• Brambilla, R. et al. Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182, 2628–2640 (2009).
  CAS PubMed Google Scholar
• Kim, R. Y. et al. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 274, 53–61 (2014).
  CAS PubMed PubMed Central Google Scholar
• Moreno, M. et al. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J. Neurosci. 34, 8175–8185 (2014).
  PubMed PubMed Central Google Scholar
• Ko, E. M. et al. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. J. Neuroinflammation 11, 105 (2014).
  PubMed PubMed Central Google Scholar
• Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A. & John, G. R. VEGF-mediated disruption of endothelial CLN-5 promotes blood–brain barrier breakdown. Proc. Natl Acad. Sci. USA 106, 1977–1982 (2009).
  CAS PubMed PubMed Central Google Scholar
• Argaw, A. T. et al. Astrocyte-derived VEGF-A drives blood–brain barrier disruption in CNS inflammatory disease. J. Clin. Invest. 122, 2454–2468 (2012). This study shows that an astrocyte-derived molecule, VEGFA, could increase permeability of the BBB and facilitate CNS entry of inflammatory cells.
  CAS PubMed PubMed Central Google Scholar
• Kang, Z. et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414–425 (2010).
  CAS PubMed PubMed Central Google Scholar
• Xanthos, D. N. & Sandkuhler, J. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nature Rev. Neurosci. 15, 43–53 (2014).
  CAS Google Scholar
• Abbott, N. J., Ronnback, L. & Hansson, E. Astrocyte–endothelial interactions at the blood–brain barrier. Nature Rev. Neurosci. 7, 41–53 (2006).
  CAS Google Scholar
• Alvarez, J. I. et al. The Hedgehog pathway promotes blood–brain barrier integrity and CNS immune quiescence. Science 334, 1727–1731 (2011).
  CAS PubMed Google Scholar
• Alvarez, J. I., Katayama, T. & Prat, A. Glial influence on the blood brain barrier. Glia 61, 1939–1958 (2013).
  PubMed PubMed Central Google Scholar
• Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512–516 (2012). This study shows that an astrocyte-derived molecule, APOE, could facilitate maintenance BBB integrity and thereby protect against CNS inflammation.
  CAS PubMed PubMed Central Google Scholar
• Herrmann, J. E. et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231–7243 (2008).
  CAS PubMed PubMed Central Google Scholar
• Drogemuller, K. et al. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J. Immunol. 181, 2683–2693 (2008). This transgenic loss-of-function study shows that astrocytes have important functions in restricting the spread of CNS infections.
  PubMed Google Scholar
• Haroon, F. et al. GP130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. J. Immunol. 186, 6521–6531 (2011).
  CAS PubMed Google Scholar
• Middeldorp, J. & Hol, E. M. GFAP in health and disease. Prog. Neurobiol. 93, 421–443 (2011).
  CAS PubMed Google Scholar
• Liedtke, W., Edelmann, W., Chiu, F. C., Kucherlapati, R. & Raine, C. S. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am. J. Pathol. 152, 251–259 (1998).
  CAS PubMed PubMed Central Google Scholar
• Macauley, S. L., Pekny, M. & Sands, M. S. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J. Neurosci. 31, 15575–15585 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kraft, A. W. et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27, 187–198 (2013). This transgenic loss-of-function study shows that reactive astrogliosis helps to restrict amyloid plaque pathology.
  CAS PubMed PubMed Central Google Scholar
• Norden, D. M., Fenn, A. M., Dugan, A. & Godbout, J. P. TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 62, 881–895 (2014).
  PubMed PubMed Central Google Scholar
• Cekanaviciute, E. et al. Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia 62, 1227–1240 (2014). This transgenic loss-of-function study shows that TGFβ signalling in reactive astrocytes reduces CNS inflammation after stroke.
  PubMed PubMed Central Google Scholar
• Cekanaviciute, E. et al. Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J. Immunol. 193, 139–149 (2014).
  CAS PubMed Google Scholar
• Min, K. J., Yang, M. S., Kim, S. U., Jou, I. & Joe, E. H. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26, 1880–1887 (2006).
  CAS PubMed PubMed Central Google Scholar
• Kostianovsky, A. M., Maier, L. M., Anderson, R. C., Bruce, J. N. & Anderson, D. E. Astrocytic regulation of human monocytic/microglial activation. J. Immunol. 181, 5425–5432 (2008).
  CAS PubMed Google Scholar
• Mizee, M. R. et al. Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function in multiple sclerosis. Acta Neuropathol. 128, 691–703 (2014).
  CAS PubMed Google Scholar
• Catrysse, L., Vereecke, L., Beyaert, R. & van Loo, G. A20 in inflammation and autoimmunity. Trends Immunol. 35, 22–31 (2014).
  CAS PubMed Google Scholar
• Wang, X. et al. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol. 126, 711–724 (2013).
  CAS PubMed Google Scholar
• Shao, W. et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature 494, 90–94 (2013).
  CAS PubMed Google Scholar
• Ousman, S. S. et al. Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature 448, 474–479 (2007). This study shows that reactive astrocytes reduce CNS inflammation through a CRYAB-dependent mechanism in autoimmune encephalomyelitis.
  CAS PubMed Google Scholar
• Steelman, A. J., Smith, R. 3rd, Welsh, C. J. & Li, J. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis. J. Biol. Chem. 288, 23776–23787 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hutchison, E. R. et al. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia 61, 1018–1028 (2013).
  PubMed PubMed Central Google Scholar
• Spence, R. D. & Voskuhl, R. R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front. Neuroendocrinol. 33, 105–115 (2012).
  CAS PubMed Google Scholar
• Spence, R. D. et al. Neuroprotection mediated through estrogen receptor-α in astrocytes. Proc. Natl Acad. Sci. USA 108, 8867–8872 (2011). This transgenic loss-of-function study shows that reactive astrocytes can reduce CNS inflammation in autoimmune encephalomyelitis via an ERα-dependent mechanism.
  CAS PubMed PubMed Central Google Scholar
• Spence, R. D. et al. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. J. Neurosci. 33, 10924–10933 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rot, A. & von Andrian, U. H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891–928 (2004).
  CAS PubMed Google Scholar
• Allen, C. D., Okada, T. & Cyster, J. G. Germinal-center organization and cellular dynamics. Immunity 27, 190–202 (2007).
  CAS PubMed PubMed Central Google Scholar
• Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nature Rev. Immunol. 6, 205–217 (2006).
  CAS Google Scholar
• Franciotta, D., Salvetti, M., Lolli, F., Serafini, B. & Aloisi, F. B cells and multiple sclerosis. Lancet Neurol. 7, 852–858 (2008).
  CAS PubMed Google Scholar
• Peters, A. et al. TH17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35, 986–996 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188–2197 (2011).
  CAS PubMed PubMed Central Google Scholar
• Metcalf, T. U., Baxter, V. K., Nilaratanakul, V. & Griffin, D. E. Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis. J. Virol. 87, 2420–2429 (2013).
  CAS PubMed PubMed Central Google Scholar
• Pohl, M. et al. T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol. Commun. 1, 85 (2013).
  PubMed PubMed Central Google Scholar
• Yamagata, K., Nakayama, C. & Suzuki, K. Dietary β-carotene regulates interleukin-1β-induced expression of apolipoprotein E in astrocytes isolated from stroke-prone spontaneously hypertensive rats. Neurochem. Int. 62, 43–49 (2013).
  CAS PubMed Google Scholar
• Mahley, R. W. & Huang, Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76, 871–885 (2012).
  CAS PubMed PubMed Central Google Scholar
• Halassa, M. M. & Haydon, P. G. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu. Rev. Physiol. 72, 335–355 (2010).
  CAS PubMed PubMed Central Google Scholar
• Tong, X. et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nature Neurosci. 17, 694–703 (2014).
  CAS PubMed Google Scholar
• Sofroniew, M. V. Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscientist 20, 160–172 (2014).
  CAS PubMed Google Scholar
• Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic–spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473–477 (2005). This study identifies the astrocyte protein AQP4 as the target of autoimmune antibodies in NMO, thereby providing both a diagnostic tool and a mechanistic target that have revolutionized understanding of this disorder.
  CAS PubMed PubMed Central Google Scholar
• Roemer, S. F. et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130, 1194–1205 (2007).
  PubMed Google Scholar
• Saadoun, S. et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133, 349–361 (2010).
  PubMed PubMed Central Google Scholar
• Howe, C. L. et al. Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures. Glia 62, 692–708 (2014).
  PubMed PubMed Central Google Scholar
• Kitley, J. et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 71, 276–283 (2014).
  PubMed Google Scholar
• Sato, D. K. et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82, 474–481 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hoftberger, R. et al. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult. Scler. http://dx.doi.org/10.1177/1352458514555785 (2014).
• Zamvil, S. S. & Slavin, A. J. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol. Neuroimmunol. Neuroinflamm. 2, e62 (2015).
  PubMed PubMed Central Google Scholar
• Diamond, B., Huerta, P. T., Mina-Osorio, P., Kowal, C. & Volpe, B. T. Losing your nerves? Maybe it's the antibodies. Nature Rev. Immunol. 9, 449–456 (2009).
  CAS Google Scholar
• Kowarik, M. C. et al. The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations. J. Neuroinflammation 12, 19 (2015).
  PubMed PubMed Central Google Scholar
• Khakh, B. S. & Sofroniew, M. V. Astrocytes and Huntington's disease. ACS Chem. Neurosci. 5, 494–496 (2014).
  CAS PubMed PubMed Central Google Scholar
• Papadopoulos, M. C., Bennett, J. L. & Verkman, A. S. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nature Rev. Neurol. 10, 493–506 (2014).
  CAS Google Scholar
• Srivastava, R. et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 367, 115–123 (2012).
  CAS PubMed PubMed Central Google Scholar
• Brickshawana, A. et al. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 13, 795–806 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ngo, S. T., Steyn, F. J. & McCombe, P. A. Gender differences in autoimmune disease. Front. Neuroendocrinol. 35, 347–369 (2014).
  CAS PubMed Google Scholar
• Voskuhl, R. Sex differences in autoimmune diseases. Biol. Sex Differ. 2, 1 (2011).
  PubMed PubMed Central Google Scholar
• Stephan, A. H., Barres, B. A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35, 369–389 (2012).
  CAS PubMed Google Scholar
• Clarke, L. E. & Barres, B. A. Emerging roles of astrocytes in neural circuit development. Nature Rev. Neurosci. 14, 311–321 (2013).
  CAS Google Scholar
• Rappold, P. M. & Tieu, K. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7, 413–423 (2010).
  CAS PubMed PubMed Central Google Scholar
• Failli, V. et al. Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain 135, 3238–3250 (2012).
  PubMed Google Scholar
• Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006).
  PubMed Google Scholar
• Hansen, R. R. & Malcangio, M. Astrocytes — multitaskers in chronic pain. Eur. J. Pharmacol. 716, 120–128 (2013).
  CAS PubMed Google Scholar
• Paradise, M. B., Naismith, S. L., Norrie, L. M., Graeber, M. B. & Hickie, I. B. The role of glia in late-life depression. Int. Psychogeriatr. 24, 1878–1890 (2012).
  PubMed Google Scholar
• Martin, J. L., Magistretti, P. J. & Allaman, I. Regulation of neurotrophic factors and energy metabolism by antidepressants in astrocytes. Curr. Drug Targets 14, 1308–1321 (2013).
  CAS PubMed Google Scholar
• Czeh, B. & Di Benedetto, B. Antidepressants act directly on astrocytes: evidences and functional consequences. Eur. Neuropsychopharmacol 23, 171–185 (2013).
  CAS PubMed Google Scholar
• Chung, W. S. et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394–400 (2013).
  CAS PubMed PubMed Central Google Scholar
• Miller, D. B. & O'Callaghan, J. P. Depression, cytokines, and glial function. Metabolism 54, 33–38 (2005).
  CAS PubMed Google Scholar
• Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev. Neurosci. 9, 46–56 (2008).
  CAS Google Scholar
• Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446–457 (2010).
  CAS PubMed Google Scholar
• Irwin, M. R. & Cole, S. W. Reciprocal regulation of the neural and innate immune systems. Nature Rev. Immunol. 11, 625–632 (2011).
  CAS Google Scholar
• Bauer, S., Kerr, B. J. & Patterson, P. H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nature Rev. Neurosci. 8, 221–232 (2007).
  CAS Google Scholar
• Deverman, B. E. & Patterson, P. H. Cytokines and CNS development. Neuron 64, 61–78 (2009).
  CAS PubMed Google Scholar
• Patterson, P. H. Maternal infection and autism. Brain Behav. Immun. 26, 393 (2012).
  PubMed Google Scholar
• Brenner, M. et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genet. 27, 117–120 (2001).
  CAS PubMed Google Scholar
• Messing, A., Brenner, M., Feany, M. B., Nedergaard, M. & Goldman, J. E. Alexander disease. J. Neurosci. 32, 5017–5023 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lobsiger, C. S. & Cleveland, D. W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nature Neurosci. 10, 1355–1360 (2007).
  CAS PubMed Google Scholar
• Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neurosci. 10, 615–622 (2007).
  CAS PubMed Google Scholar
• Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neurosci. 11, 251–253 (2008).
  CAS PubMed Google Scholar
• Myer, D. J., Gurkoff, G. G., Lee, S. M., Hovda, D. A. & Sofroniew, M. V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129, 2761–2772 (2006).
  CAS PubMed Google Scholar
• Sahni, V. et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J. Neurosci. 30, 1839–1855 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shimada, I. S., Borders, A., Aronshtam, A. & Spees, J. L. Proliferating reactive astrocytes are regulated by Notch-1 in the peri-infarct area after stroke. Stroke 42, 3231–3237 (2011).
  PubMed PubMed Central Google Scholar
• Shimada, I. S., Lecomte, M. D., Granger, J. C., Quinlan, N. J. & Spees, J. L. Self-renewal and differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the cortical peri-infarct area after stroke. J. Neurosci. 32, 7926–7940 (2012).
  CAS PubMed PubMed Central Google Scholar
• Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R. & van Noort, J. M. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243–253 (2003).
  PubMed Google Scholar
• Jensen, C. J., Massie, A. & De Keyser, J. Immune players in the CNS: the astrocyte. J. Neuroimmune Pharmacol. 8, 824–839 (2013).
  PubMed Google Scholar
• Cooley, I. D., Chauhan, V. S., Donneyz, M. A. & Marriott, I. Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member. Glia 62, 818–828 (2014).
  PubMed PubMed Central Google Scholar
• Pitter, K. L. et al. The SHH/Gli pathway is reactivated in reactive glia and drives proliferation in response to neurodegeneration-induced lesions. Glia 62, 1595–1607 (2014).
  PubMed PubMed Central Google Scholar
• Sarafian, T. A. et al. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS ONE 5, e9532 (2010).
  PubMed PubMed Central Google Scholar
• Hong, P., Jiang, M. & Li, H. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse. Glia 62, 2044–2060 (2014).
  PubMed Google Scholar
• Krumbholz, M. et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201, 195–200 (2005).
  CAS PubMed PubMed Central Google Scholar